Tate Jeffrey

Tate Jeffrey is listed in filings as Chief Operating Officer at Cyclo Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2024, including 2 public disclosures. Recent filings connect the profile to Cyclo Therapeutics, Inc. (CYTHW) and Cyclo Therapeutics, Inc. (CYTH). The current snapshot covers public activity from Jun 5, 2024. Reported amounts are shown as $141.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.